188 related articles for article (PubMed ID: 16476479)
21. Analysis of minimal residual disease in childhood acute lymphoblastic leukemia: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping.
Malec M; van der Velden VH; Björklund E; Wijkhuijs JM; Söderhäll S; Mazur J; Björkholm M; Porwit-MacDonald A
Leukemia; 2004 Oct; 18(10):1630-6. PubMed ID: 15295608
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow minimal disseminated disease (MDD) and minimal residual disease (MRD) in childhood T-cell lymphoblastic lymphoma stage III, detected by flow cytometry (FC) and real-time quantitative polymerase chain reaction (RQ-PCR).
Stark B; Avigad S; Luria D; Manor S; Reshef-Ronen T; Avrahami G; Yaniv I
Pediatr Blood Cancer; 2009 Jan; 52(1):20-5. PubMed ID: 19006253
[TBL] [Abstract][Full Text] [Related]
23. Rapid detection of gammaT cell receptor gene rearrangements in acute lymphoblastic leukemia by electrophoresis and silver staining: implications for detection of minimal residual disease.
Valetto A; Lanciotti M; Di Martino D; Anselmi G; Bottini F; Mori P; Candiano G
Electrophoresis; 1998 Jun; 19(8-9):1385-7. PubMed ID: 9694286
[TBL] [Abstract][Full Text] [Related]
24. Diversity of T-cell receptor gene rearrangements in South Indian patients with common acute lymphoblastic leukemia.
Sudhakar N; Nancy NK; Rajalekshmy KR; Rajkumar T
Iran J Immunol; 2009 Sep; 6(3):141-6. PubMed ID: 19801787
[TBL] [Abstract][Full Text] [Related]
25. Minimal residual disease (MRD) monitoring using rearrangement of T-cell receptor and immunoglobulin H gene in the treatment of adult acute lymphoblastic leukemia patients.
Toubai T; Tanaka J; Ota S; Fukuhara T; Hashino S; Kondo T; Kasai M; Kakinoki Y; Masauzi N; Morioka M; Kawamura T; Iwasaki H; Asaka M; Imamura M
Am J Hematol; 2005 Nov; 80(3):181-7. PubMed ID: 16247752
[TBL] [Abstract][Full Text] [Related]
26. Detection of clonal immunoglobulin and T-cell receptor gene rearrangements in childhood acute lymphoblastic leukemia using a low-cost PCR strategy.
Assumpção JG; Ganazza MA; de Araújo M; Silva AS; Scrideli CA; Brandalise SR; Yunes JA
Pediatr Blood Cancer; 2010 Dec; 55(7):1278-86. PubMed ID: 20730889
[TBL] [Abstract][Full Text] [Related]
27. [Tandem application of flow cytometry and polymerase chain reaction for choice targets of minimal residual disease in childhood acute lymphoblastic leukemia].
Tie LJ; Gu LJ; Jiang LM; Zhao JC; Chen J; Pan C; Dong L; Chen J; Xue HL; Tang JY; Wang YP
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):246-50. PubMed ID: 19374803
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis.
Beishuizen A; Verhoeven MA; van Wering ER; Hählen K; Hooijkaas H; van Dongen JJ
Blood; 1994 Apr; 83(8):2238-47. PubMed ID: 8161789
[TBL] [Abstract][Full Text] [Related]
29. TCRB gene rearrangements in childhood and adult precursor-B-ALL: frequency, applicability as MRD-PCR target, and stability between diagnosis and relapse.
van der Velden VH; Brüggemann M; Hoogeveen PG; de Bie M; Hart PG; Raff T; Pfeifer H; Lüschen S; Szczepański T; van Wering ER; Kneba M; van Dongen JJ
Leukemia; 2004 Dec; 18(12):1971-80. PubMed ID: 15470492
[TBL] [Abstract][Full Text] [Related]
30. Immunoglobulin light chain gene rearrangements in precursor-B-acute lymphoblastic leukemia: characteristics and applicability for the detection of minimal residual disease.
van der Velden VH; de Bie M; van Wering ER; van Dongen JJ
Haematologica; 2006 May; 91(5):679-82. PubMed ID: 16627258
[TBL] [Abstract][Full Text] [Related]
31. T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis.
van der Velden VH; Wijkhuijs JM; Jacobs DC; van Wering ER; van Dongen JJ
Leukemia; 2002 Jul; 16(7):1372-80. PubMed ID: 12094263
[TBL] [Abstract][Full Text] [Related]
32. Lack of clinical utility of minimal residual disease detection in allogeneic stem cell recipients with childhood acute lymphoblastic leukemia: multi-institutional collaborative study in Japan.
Imashuku S; Terui K; Matsuyama T; Asami K; Tsuchiya S; Ishii E; Kawa K; Kosaka Y; Eguchi H; Tsuchida M; Ikuta K; Kato S; Koizumi S; Okamura J; Morimoto A; Hibi S; Hamaoka K;
Bone Marrow Transplant; 2003 Jun; 31(12):1127-35. PubMed ID: 12796792
[TBL] [Abstract][Full Text] [Related]
33. T-cell receptor gamma and delta gene rearrangements and junctional region characteristics in south Indian patients with T-cell acute lymphoblastic leukemia.
Sudhakar N; Nancy NK; Rajalekshmy KR; Ramanan G; Rajkumar T
Am J Hematol; 2007 Mar; 82(3):215-21. PubMed ID: 17133429
[TBL] [Abstract][Full Text] [Related]
34. Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes.
Pongers-Willemse MJ; Verhagen OJ; Tibbe GJ; Wijkhuijs AJ; de Haas V; Roovers E; van der Schoot CE; van Dongen JJ
Leukemia; 1998 Dec; 12(12):2006-14. PubMed ID: 9844931
[TBL] [Abstract][Full Text] [Related]
35. Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B-ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease.
Szczepański T; Willemse MJ; Brinkhof B; van Wering ER; van der Burg M; van Dongen JJ
Blood; 2002 Apr; 99(7):2315-23. PubMed ID: 11895762
[TBL] [Abstract][Full Text] [Related]
36. Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia.
Szczepański T; Flohr T; van der Velden VH; Bartram CR; van Dongen JJ
Best Pract Res Clin Haematol; 2002 Mar; 15(1):37-57. PubMed ID: 11987915
[TBL] [Abstract][Full Text] [Related]
37. [Development of a new strategy for minimal residual disease monitoring in children with B-precursor acute lymphoblastic leukemia].
Bonjean B; Grollet L; Visentin E; Sigaux F; Cayuela JM
Ann Biol Clin (Paris); 2004; 62(4):465-70. PubMed ID: 15297244
[TBL] [Abstract][Full Text] [Related]
38. [Immunoglobulin super-gene family and its related genes in detecting MRD in ALL].
Dong S; Kuang S; Huang W
Zhonghua Yi Xue Za Zhi; 1996 Oct; 76(10):742-6. PubMed ID: 9275514
[TBL] [Abstract][Full Text] [Related]
39. A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia.
Guidal C; Vilmer E; Grandchamp B; Cavé H
Leukemia; 2002 Apr; 16(4):762-4. PubMed ID: 11960365
[No Abstract] [Full Text] [Related]
40. MRD detection in acute lymphoblastic leukemia patients using Ig/TCR gene rearrangements as targets for real-time quantitative PCR.
van der Velden VH; van Dongen JJ
Methods Mol Biol; 2009; 538():115-50. PubMed ID: 19277574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]